Francis X. Acunzo Is Raising Awareness in Aesthetic Industry About Hydroquinone Regulatory Changes

Posted By American Med Spa Association, Thursday, January 7, 2021

Medical spa pioneer Francis X. Acunzo, founder and CEO of Acara Partners, is working to inform owners and physicians in the aesthetic medical industry about new regulations and limitations to the sale of over-the-counter (OTC) drugs containing hydroquinone, and how this will impact their businesses. Acunzo is owner and founder of Acara Partners, a full-service consultancy and marketing agency dedicated to the aesthetic medical industry.
As part of the passage of the Coronavirus Aid, Relief and Economic Security (CARES) ACT on March 27, 2020, Congress made significant changes to how OTC products containing hydroquinone are regulated and dispensed. These changes became effective on September 23, 2020, when all OTC products containing hydroquinone had to be removed from the market. Currently, products containing hydroquinone can only be distributed if they are approved by the U.S. Food and Drug Administration (FDA) through the new drug application process or if the compounds are patient-specific prescriptions. Physicians must comply with FDA regulations, as well as state and local pharmacy regulations before dispensing products and prescriptions containing hydroquinone.
Read more at PRWeb >>